Statement of the DOG, RG and BVA on Anti-VEGF Therapy in neovascular age-related Macular Degeneration

被引：0

作者：

机构：

[1] Deutsch Ophthalmol Gesell, Platenstr 1, D-80336 Munich, Germany

[2] Retinol Gesell eV, Freiburg, Germany

[3] Berufsverband Augenarzte Deutschlands eV, Dusseldorf, Germany

来源：

关键词：

ENDOTHELIAL GROWTH-FACTOR; RANIBIZUMAB TREATMENT; CLINICAL BURDEN; VISUAL-ACUITY; PLAN REGIMEN; OUTCOMES; TREAT; EFFICACY; VERTEPORFIN; BEVACIZUMAB;

D O I：

10.1055/a-1191-1433

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：995 / 1003

页数：9

共 54 条

Abedi, Farshad ;

Wickremasinghe, Sanjeewa ;

Islam, Amirul F. M. ;

Inglis, Kellie M. ;

Guymer, Robyn H. .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (08) :1531-1538

[2]

[Anonymous], 2011, OPHTHALMOLOGE, V1, P86

[3]

[Anonymous], 2017, OPHTHALMOLOGE, V114, P220

[4]

[Anonymous], 2015, OPHTHALMOLOGE, V112, P237

[5]

[Anonymous], 2013, KLIN MONBL AUGENHEIL, V230, P170

[6]

[Anonymous], 2011, KLIN MONBL AUGENHEIL, V228, P138

[7]

[Anonymous], 2013, OPHTHALMOLOGE, V110, P405

[8]

[Anonymous], 2009, KLIN MONBL AUGENHEIL, V226, P388

[9]

[Anonymous], 2012, OPHTHALMOLOGE, V109, P405

[10]

[Anonymous], 2017, KLIN MONATSBL AUGENH, V234, P650